Bridging the Gaps

New Directions and Practice Impacting Recommendations in Multiple Sclerosis
Faculty presenters: Erin Longbrake, MD, PhD (Meeting Chair and Publication Editor); Stephen Krieger, MD; Carrie M. Hersh, DO, MSc, FAAN; Jens Kuhle, MD, PhD; Pascal Sati, PhD; Robert T. Naismith, MD; Fredrik Piehl, MD; Riley Bove, MD; and Ahmed Z. Obeidat, MD.
This NeurologyLive supplement comprises 3 articles that review the evolving biological understanding of multiple sclerosis (MS) and the associated implications for treatment. The publication also explores emerging biomarkers in MS as well as the latest ideas on the use of disease-modifying therapies, including scenarios for starting, switching, or stopping immunotherapy.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NeurologyLive® Friday 5 — November 7, 2025
2
Survey Study Highlights Interest, Motivations Behind Modifier Gene Testing for Huntington Disease
3
Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation
4
Neflamapimod Phase 3 Trial in DLB, Troriluzole Gets CRL for SCA, Periodontal Disease and Stroke Risk
5











